No offense, but that’s rubbish.
I’ve been in the stock from 1 cent, bought all along the journey, including recently and own some of those options from the placement.
No one is “dumping” and you have missed the point entirely.
IHL has a real chance of being a massive success and the real supporters are not in this for 100% returns. Ask
@Chaya about his opinion, he’s in the top 10. Most junior stocks on the ASX will have listed or unlisted options in their capital structure.
IHL is actually better value today than it was 12 months ago IMO even though the price was lower and that’s due to the progress and success on the clinical trials.
Canary Capital have bought a substantial position and according to my broker are still buying at 17c. I can assure you they are extremely capable and across every aspect of the story, including the capital structure.
